(Press-News.org) Research on treatments for health problems, such as diabetes, stroke and schizophrenia, is not being focused on the treatments considered most important by patients and clinicians, according to a study published in the open access journal Research Involvement and Engagement.
The study suggests that current research is instead favoring drug treatments over physical or psychological therapies, or interventions to improve educational approaches or service organization.
Study author Iain Chalmers, one of the founders of the Cochrane Collaboration and James Lind Alliance, said: "We have confirmed earlier, less extensive studies indicating important mismatches between what patients and health professionals want to see researched, and the research that is actually done. On average, patients and clinicians prefer the evaluation of non-drug treatments, while researchers tend to prioritise studies into drug treatments.
"This discrepancy was first uncovered 15 years ago, and so it is disappointing that the situation still has not improved. The research community needs to make greater efforts to involve patients and health care professionals in setting research agendas, and take account of their views."
The James Lind Alliance is an initiative that establishes partnerships between patients, carers and clinicians to inform treatment research agendas. Each of these 'Priority Setting Partnerships' (PSPs) identifies the top research priorities relating to specific health problems, including Type 1 diabetes, schizophrenia, stroke and eczema.
In the study, the researchers identified the research priorities of 14 PSPs, which highlighted 126 different treatments. They then compared these with the treatments being studied in UK clinical trials registered between 2003 and 2012 in the WHO's International Clinical Trials Registry Platform. These included 1,682 research studies (53% non-commercial research, 47% commercially-funded).
The results revealed marked differences between the types of treatments highlighted by patients, carers and clinicians as priorities, and those being evaluated by researchers. In PSPs, drug interventions accounted for only 18% of the treatments mentioned as priorities, while they accounted for 37% of treatments evaluated in non-commercial trials and 86% of treatments evaluated in commercial trials.
A very low proportion (2.6%) of registered commercial trials studied the effects of the non-drug treatments that were priorities for patients and clinicians. The authors say this suggests that few of the drug trials can have used non-drug comparators, for example, comparing anti-depressant drugs with psychological therapies for treating depression.
The study suggests there may also be 'methodological disincentives' for researchers to include non-drug comparators. This is because designing, running and interpreting drug trials will usually be more straightforward compared with evaluating psychological or physical therapies, and other non-drug treatments.
The authors say that an obvious explanation for this mismatch is that the users of research evidence - patients, carers and clinicians - apparently only very rarely contribute to setting research agendas. Therefore the research questions rated as important to them may simply never occur to researchers.
They add: "If research is to reflect the priorities of patients and clinicians, leadership and incentives will be needed. The current research 'system' and culture is not geared to bridging the mismatch we have documented."
The authors warn that similar findings may not necessarily result in replication of similar analyses done for other health problems, or for replications that are not limited to the very highest priorities that the PSPs aim to identify.
The research article marks the launch of the open access journal Research Involvement and Engagement, which recognises the importance of patient and the wider public input in co-producing knowledge. The Editorial Board is representative of both patients and academics, with all articles peer reviewed by both groups and carrying equal weight in the editorial decision.
INFORMATION:
Media Contact
Joel Winston
Media Officer
BioMed Central
T: +44 (0)20 3192 2081
M: +44 (0)7766540147
E: Joel.Winston@biomedcentral.com
Notes to editor:
1. Research article
Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch
Sally Crowe, Mark Fenton, Matthew Hall, Katherine Cowan and Iain Chalmers
Research Involvement and Engagement 2015
doi: 10.1186/s40900-015-0003-x
For an embargoed copy of the research article, please contact Joel.Winston@biomedcentral.com
After embargo, article available at journal website here: http://dx.doi.org/10.1186/s40900-015-0003-x
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. Research Involvement and Engagement is an interdisciplinary, health and social care journal focussing on patient and wider involvement and engagement in research, at all stages. The journal is co-produced by all key stakeholders, including patients, academics, policy makers and service users.
RI&E provides a platform for articles that contribute to the evidence base for involvement and engagement in research, that develop our understanding of the concept, theory, and methods of involvement and engagement at all stages of the research process, as well as evaluations and analyses. It aims to enhance the quality of the involvement and experiences evidence-base to inform effective practice.
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. http://www.biomedcentral.com
A single supportive close friendship can help young people from low-income backgrounds to thrive in challenging circumstances, according to a new University of Sussex study.
The research, led by psychologist Dr Rebecca Graber, is published today, Thursday 25 June, in the British Journal of Psychology.
Young people from low-income areas typically face substantial challenges to good physical health, mental health, academic achievement and employment.
Previous research has linked these challenges to involvement with peers and membership of larger friendship groups - ...
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are "unable or unwilling to quit." The strategy, embraced by both industry and some public health advocates, is based on the assumption that as smoking declines overall, only those who cannot quit will remain. A new study by researchers at UC San Francisco has found just the opposite.
The researchers analyzed survey data spanning 18 years in the United States and six years in the European Union. They found that, contrary to the prevailing assumptions, ...
An investigation published by The BMJ today reveals how the controversial concept of "harm reduction", embraced enthusiastically by the tobacco industry, has sharply divided the public health community.
On one side of the increasingly bitter dispute are those who believe it is time to work with the industry in support of products such as e-cigarettes.
Those in the other camp, however, not only contest the claimed public health benefits of the new products but also fear harm reduction is a cynical and superficial smokescreen for an industry that has every intention of ...
Women who have experienced a stillbirth have up to a fourfold increased risk of stillbirth in a second pregnancy compared to those who had an initial live birth, finds a new meta-analysis published in The BMJ this week.
Stillbirth rates have declined across most of Europe, but the UK still has a major public health problem. Ranked 33rd out of 35 for stillbirth rates among European countries, the UK recorded 3,286 stillborn babies in 2013.
"Stillbirth is one of the most common adverse obstetric outcomes and a traumatic experience for parents," explain Sohinee Bhattacharya ...
Countries most affected by HIV must focus on stopping new HIV infections and expanding access to antiretroviral treatment or risk the epidemic rebounding, urges a major new report from the UNAIDS and Lancet Commission.
"We must face hard truths--if the current rate of new HIV infections continues, merely sustaining the major efforts we already have in place will not be enough to stop deaths from AIDS increasing within five years in many countries," said Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine, Co-Chair of the Commission, and ...
Congress needs to immediately lift the ban on federal funding for needle exchange programs to counter the threat of HIV outbreaks among injection drug users like the one that has seen an alarming number of new cases erupt in a single rural Indiana county.
So say Johns Hopkins Bloomberg School of Public Health Professor Chris Beyrer, MD, MPH, and Steffanie A. Strathdee, PhD, director of the Institute of Global Health at the University of California-San Diego, in a commentary published online June 24 in The New England Journal of Medicine.
"There are going to be more ...
DALLAS, June 24, 2015 -- Nearly half of Hispanic adults were unaware they have high cholesterol, and less than a third receive any kind of cholesterol treatment, in a new study in Journal of the American Heart Association.
Hispanics are one of the fastest growing ethnic groups in America, with 52 million among the U.S. population, yet their awareness and management of high cholesterol lags behind other ethnic groups. Educating Hispanics/Latinos about the importance of maintaining healthy cholesterol levels could have a significant public health impact on reducing the ...
COLUMBIA, Mo. - When older adults transfer between nursing homes and hospitals, inefficient and unclear communication between the organizations can hinder patient care. Now, a team of MU researchers is working to improve patients' health outcomes by increasing efficient, secure communication between nursing homes and hospitals using an electronic communication system called a health information exchange (HIE).
"The exchange of accurate, complete and timely information between hospitals and nursing homes can be complicated when older adults transfer from one place to another," ...
Putnam Valley, N.Y. (June 24, 2015) - Cell transplantation researchers have successfully used bone marrow-derived mesenchymal stromal cells (MSCs) to treat a variety of diseases and conditions. Now, using injections of MSCs, a research team in Brazil has successfully treated laboratory rats modeled with severe burns. They found that the MSCs accelerated healing, enhanced local blood supply, affected the immune system in a positive way, secreted beneficial growth factors with anti-inflammatory properties, and ultimately provided higher survival rates than in control animals ...
Urinary tract and sexually transmitted infections in women are misdiagnosed by emergency departments nearly half the time, according to a paper in the Journal of Clinical Microbiology, a publication of the American Society for Microbiology. These misdiagnoses result in overuse of antibiotics, and increased antibiotic resistance, according to Michelle Hecker, MD, an assistant professor in the Department of Medicine, Division of Infectious Diseases, MetroHealth Medical Center, Case Western Reserve University, Cleveland, and her collaborators.
"Less than half the women ...
